Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
39.2M
-
Shares change
-
+206K
-
Total reported value, excl. options
-
$228M
-
Value change
-
+$79.7K
-
Put/Call ratio
-
0.76
-
Number of buys
-
62
-
Number of sells
-
-70
-
Price
-
$5.80
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q3 2024
160 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q3 2024.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.2M shares
of 63.2M outstanding shares and own 62.13% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (6.2M shares), BlackRock, Inc. (4.18M shares), MORGAN STANLEY (3.27M shares), VANGUARD GROUP INC (2.74M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.39M shares), DEUTSCHE BANK AG\ (2.06M shares), CIBC Private Wealth Group LLC (1.89M shares), GAGNON SECURITIES LLC (1.77M shares), JPMORGAN CHASE & CO (1.26M shares), and D. E. Shaw & Co., Inc. (1.14M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.